Skip to main content
Corporate report

MHRA Women’s Health Programme 2026-2030

The Women’s Health Programme supports better evidence and regulation of medicines and medical devices to improve health outcomes for women.

Documents

Our plan to support women’s health: MHRA Women’s Health Programme 2026-2030 (easy read version)

Request an accessible format
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Our Strategy to 2030 sets out how to deliver health and prosperity for all, through scientific excellence. One of our strategic priorities within this strategy is to deliver proactive regulation to address evidence gaps and reduce inequalities.

Our Women’s Health Programme 2026 to 2030 supports work to improve the safety and effectiveness of medicines and medical devices used by women, and to ensure women’s needs are better reflected in healthcare research and regulation.

Sign up for emails or print this page